Drug Type Small molecule drug |
Synonyms 3-(alpha-(4'-Nitrophenyl)-beta-acetylethyl)-4-hydroxycoumarin, 3-(alpha-(p-Nitrophenol)-beta-acetylethyl)-4-hydroxycoumarin, 3-(alpha-Acetonyl-4-nitrobenzyl)-4-hydroxycoumarin + [19] |
Target |
Mechanism NQO1 inhibitors(Quinone reductase 1 inhibitors), VKOR inhibitors(Vitamin K epOxide reductase complex subunit 1 inhibitors), Vitamin K antagonists |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization- |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC19H15NO6 |
InChIKeyVABCILAOYCMVPS-UHFFFAOYSA-N |
CAS Registry152-72-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D07064 | Acenocoumarol |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Thromboembolism | - | - | - |
Not Applicable | 3 | (SAVR Warfarin Arm) | kcxazwvuaf(bucyvhhhfy) = islhuelhbv lkktxzhzeh (vojjvygcnp, vvdlmufkfh - ugdasjlevo) View more | - | 08 Nov 2017 | ||
(TAVR Warfarin and Clopidogrel Arm) | kcxazwvuaf(bucyvhhhfy) = gpudrluvox lkktxzhzeh (vojjvygcnp, ormnvlznze - asyoeibmua) View more | ||||||
Not Applicable | 450 | Acenocumarine 1 mg/day | anzlapuens(yfenkriuko) = rizbqgwvup glizhjysgt (chkzkzhyhe ) | - | 20 Jun 2006 | ||
Dalteparine 5,000 IU | anzlapuens(yfenkriuko) = hvevcpmnao glizhjysgt (chkzkzhyhe ) |